Understanding how glucocorticoid gene regulation affects leukemia treatment
Deciphering the underlying structure of the glucocorticoid gene regulatory network
['FUNDING_R01'] · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · NIH-11025209
This study is looking at how certain genes affect how well glucocorticoid medications work for patients with B-cell acute lymphoblastic leukemia, especially for those who struggle with treatment resistance, to help find better ways to improve their response to these important drugs.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | ST. JUDE CHILDREN'S RESEARCH HOSPITAL (nih funded) |
| Locations | 1 site (MEMPHIS, UNITED STATES) |
| Trial ID | NIH-11025209 on ClinicalTrials.gov |
What this research studies
This research investigates the glucocorticoid gene regulatory network, which plays a crucial role in how cells respond to glucocorticoids, a type of steroid medication commonly used to treat conditions like leukemia and autoimmune diseases. By examining the genetic elements that influence this network, researchers aim to uncover why some patients with B-cell acute lymphoblastic leukemia (B-ALL) develop resistance to glucocorticoid treatment. The study employs advanced techniques to analyze genetic variations and their effects on cell behavior, particularly focusing on apoptosis, or programmed cell death, which is essential for effective cancer treatment. Patients may benefit from a deeper understanding of their treatment responses and potential new strategies to overcome drug resistance.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients diagnosed with B-cell acute lymphoblastic leukemia who are undergoing glucocorticoid treatment.
Not a fit: Patients with other types of leukemia or those not receiving glucocorticoid therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies for patients with B-ALL, particularly those who experience glucocorticoid resistance.
How similar studies have performed: Previous research has shown that understanding gene regulatory networks can lead to significant advancements in treatment strategies for various cancers, indicating a promising avenue for this study.
Where this research is happening
MEMPHIS, UNITED STATES
- ST. JUDE CHILDREN'S RESEARCH HOSPITAL — MEMPHIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SAVIC, DANIEL — ST. JUDE CHILDREN'S RESEARCH HOSPITAL
- Study coordinator: SAVIC, DANIEL
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Autoimmune Diseases, autoimmune disorder, autoimmunity disease